RE:RE:Silver liningHow will they attract somebody for the oncology manager they reupped the job offer a week ago? This is freakin misleading, maybe not intentionally, but it just makes no sense to search somebody to fill this job with the situation they are in now.
SPCEO1 wrote: Tomorrow will be rough but there really never has been any value given to cancer, so with lower costs during the pause, earnings should be better. And only one analyst, the most recent one from Jones, had ascribed any value for cancer. So, technically, he should be the only one lowering his price target. Somehow, the others will likely do so also anyway.
It was suspicious that they had a non-cancer focused Q3 call and now I suppose we know why.
SABBOBCAT wrote: The stock price doesn't reflect any value for oncology so we have nothing to lose... Right???? Tomorrow is going to be rough